Marching Ahead through the Pandemic: Continuing Anesthesia Services in COVID Era—Our Experience from a Tertiary Care Cancer Centre

Abstract

Swati Bhan

Introduction This paper aims to provide an overview of the administrative and clinical preparations done in a tertiary care cancer hospital in continuing operation theatre (OT) services through the COVID pandemic.

Methods Retrospective data collection, data for the past 1.5 years (COVID period) March 2020 to August 2021 were compared to surgical output for a similar duration of time before the COVID era (September 2018–February 2020).

Results A total of 1,022 surgeries were done under anesthesia in the COVID period as against 1,710 surgeries done in a similar time frame in the pre-COVID era. Overall, we saw a 40%drop in the total number of cases. Thorax, abdominal, and miscellaneous surgeries (soft tissue sarcomas, urology, and gyneconcology) saw a maximum fall in numbers; however, head and neck cases saw an increase in numbers during the pandemic. Surgical morbidity and mortality were similar in the COVID and pre-COVID era. No cases of severe COVID infection were reported among the healthcare staff working in OT.

Discussion We could successfully continue our anesthesia services with minimal risk to healthcare staff throughout the pandemic by adopting major guidelines in a pragmatic and practical approach with minor changes to suit our setup.

Keywords

COVID-19 - pandemic - anesthesia - cancer care

Authors' Contribution

Swati Bhan led the data collection, tabulation, and literature review, as well as manuscript writing. Raghav Gupta contributed to data collection and tabulation, while Saurabh Vig focused on literature review, data interpretation, and manuscript writing. Editing of the manuscript was conducted by Rakesh Garg, Nishkarsh Gupta, Vinod Kumar, Sachidanand Jee Bharati, Seema Mishra, Brajesh Ratre, Anuja Pandit, Prashant Sirohiya, Ram Singh, Balbir Kumar, and Shweta Bhopale, with Seema Mishra also involved in literature review. Brajesh Ratre and Anuja Pandit primarily handled literature review tasks, while Sushma Bhatnagar significantly contributed to the conception of the idea, literature review, and final manuscript editing. All authors have thoroughly reviewed and approved the manuscript.

Ethical Approval

Not applicable (retrospective data collection), manuscript adheres to Helsinki guidelines.

Publication History

Article published online:
02 March 2023

• References

• 1 Coronavirus Second Wave, Third Wave and Beyond: What Causes a COVID Surge. Accessed December 7, 2021 at: https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/first-and-second-waves-of-coronavirus
• 2 Hamid H, Abid Z, Amir A, Rehman TU, Akram W, Mehboob T. Current burden on healthcare systems in low- and middle-income countries: recommendations for emergency care of COVID-19. Drugs Ther Perspect 2020; 36 (10) 466-468
• 3 Miller IF, Becker AD, Grenfell BT, Metcalf CJE. Disease and healthcare burden of COVID-19 in the United States. Nat Med 2020; 26 (08) 1212-1217
• 4 Rosenbaum L. The untold toll - the pandemic's effects on patients without COVID-19. N Engl J Med 2020; 382 (24) 2368-2371
• 5 Dhar N, Madhaw G, Kumar M, Kumar N, Tiwari A, Jatale V. Non-COVID neurological emergencies: a silent killer going unnoticed during COVID-19 pandemic. J Neurosci Rural Pract 2021; 12 (03) 461-469
• 6 The Lancet Oncology. COVID-19 and cancer: 1 year on. Lancet Oncol 2021; 22 (04) 411
• 7 Riera R, Bagattini ÂM, Pacheco RL, Pachito DV, Roitberg F, Ilbawi A. Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review. JCO Glob Oncol 2021; 7 (07) 311-323
• 8 Classification of Omicron. (B.1.1.529): SARS-CoV-2 Variant of Concern. Accessed December 7, 2021 at: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern
• 9 Vaid AK, Malhotra H, Thirumalairaj R. et al. Indian expert opinion on cancer care during COVID-19 pandemic. South Asian J Cancer 2021; 10 (01) 9-18
• 10 Patwa A, Shah A, Garg R. et al. All India difficult airway association (AIDAA) consensus guidelines for airway management in the operating room during the COVID-19 pandemic. Indian J Anaesth 2020; 64 (suppl 2): S107-S115
• 11 Velly L, Gayat E, Quintard H. et al. Guidelines: anaesthesia in the context of COVID-19 pandemic. Anaesth Crit Care Pain Med 2020; 39 (03) 395-415
• 12 Solanki SL, Thota RS, Garg R. et al. Society of Onco-Anesthesia and Perioperative Care (SOAPC) advisory regarding perioperative management of onco-surgeries during COVID-19 pandemic. Indian J Anaesth 2020; 64 (suppl 2): S97-S102
• 13 Odor PM, Neun M, Bampoe S. et al. Anaesthesia and COVID-19: infection control. Br J Anaesth 2020; 125 (01) 16-24
• 14 Wong J, Goh QY, Tan Z. et al. Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore. Can J Anaesth 2020; 67 (06) 732-745
• 15 Lim WY, Wong P. Supraglottic airways in the management of COVID-19 patients. Anaesth Crit Care Pain Med 2020; 39 (05) 589-590
• 16 Use of supraglottic airways during the COVID-19 pandemic. ICM Anaesthesia COVID-19. Accessed September 26, 2021 at: https://icmanaesthesiacovid-19.org/use-of-supraglottic-airways-during-the-covid-19-pandemic
• 17 Health C for D and R. Protective Barrier Enclosures Without Negative Pressure Used During the COVID-19 Pandemic May Increase Risk to Patients and Health Care Providers - Letter to Health Care Providers. FDA. Accessed December 7, 2021 at: https://www.fda.gov/medical-devices/letters-health-care-providers/protective-barrier-enclosures-without-negative-pressure-used-during-covid-19-pandemic-may-increase